• Top visited

  • Already

    • 58,731 nanohits
  • Add to Technorati Favorites
  • Archives

  • Advertisements

New clinical trial : personalized medicine in diabetes using a nanotechnology platform

Rambam Health Care Campus in Israel will launch in collaboration with Technion/Israel Institute of Technology a phase I clinical trial about “personalized medicine in diabetes using a nanotechnology platform”, registered in the Clinicaltrials.gov database under reference NCT01268813. In this trial, breath samples will be collected in inert respiratory bag from diabetic and healthy volunteers, and analyzed using a chamber containing nano-chemical sensors. These samples together with blood samples will additionally be characterized using Gas Chromatography-Mass Spectroscopy (GC-MS). The study is not yet open for participant recruitment.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: